All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: Role of histone modification

Molecular Pharmacology

Volumn 85, Issue 6, 2014, Pages 946-957

  Kumar, Prerna ^a   Periyasamy, Ramu ^a   Das, Subhankar ^a   Neerukonda, Smitha ^a   Mani, Indra ^a   Pandey, Kailash N ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATOR COMPLEX CONTAINING E26 TRANSFORMATION SPECIFIC 1 PROTEIN; ALPHA SMOOTH MUSCLE ACTIN; BUTYRIC ACID; CYCLINE; E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE; HISTONE H3; HISTONE H4; NATRIURETIC PEPTIDE RECEPTOR A; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; UNCLASSIFIED DRUG; ATRIAL NATRIURETIC FACTOR RECEPTOR; HISTONE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DEACETYLATION; ELEVATED BLOOD PRESSURE; EPIGENETICS; GENE DOSAGE; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE CODE; HISTONE METHYLATION; HISTONE MODIFICATION; HYPERTENSION; IN VIVO STUDY; KIDNEY INTERSTITIUM; KIDNEY TUBULE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE; ANIMAL; CELL CULTURE; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

ANIMALS; BUTYRIC ACID; CELLS, CULTURED; HISTONES; MICE; RECEPTORS, ATRIAL NATRIURETIC FACTOR; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 84902981002     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.114.092221     Document Type: Article

References (60)

1. Arise KK and Pandey KN (2006) Inhibition and down-regulation of gene transcription and guanylyl cyclase activity of NPRA by angiotensin II involving protein kinase C. Biochem Biophys Res Commun 349:131-135.
2. Bastien J and Rochette-Egly C (2004) Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 328:1-16.
3. Baylin SB and Ohm JE (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107-116.
4. Bhaumik SR, Smith E, and Shilatifard A (2007) Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol 14:1008-1016.
5. Bush EW and McKinsey TA (2010) Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors. Circ Res 106:272-284.
6. Cederberg A, Hulander M, Carlsson P, and Enerbäck S (1999) The kidney-expressed winged helix transcription factor FREAC-4 is regulated by Ets-1. A possible role in kidney development. J Biol Chem 274:165-169.
7. Chen S, McCormick JA, Prabaker K, Wang J, Pearce D, and Gardner DG (2004) Sgk1 mediates osmotic induction of NPR-A gene in rat inner medullary collecting duct cells. Hypertension 43:866-871.
8. Das S, Au E, Krazit ST, and Pandey KN (2010) Targeted disruption of guanylyl cyclase-A/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: role of proinflammatory cytokines. Endocrinology 151:5841-5850.
9. de Bold AJ (1985) Atrial natriuretic factor: a hormone produced by the heart. Science 230:767-770.
10. Dietze EC, Caldwell LE, Marcom K, Collins SJ, Yee L, Swisshelm K, Hobbs KB, Bean GR, and Seewaldt VL (2002) Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300. Microsc Res Tech 59:23-40.
11. Drewett JG and Garbers DL (1994) The family of guanylyl cyclase receptors and their ligands. Endocr Rev 15:135-162.
12. Garbers DL, Chrisman TD, Wiegn P, Katafuchi T, Albanesi JP, Bielinski V, Barylko B, Redfield MM, and Burnett JC, Jr (2006) Membrane guanylyl cyclase receptors: an update. Trends Endocrinol Metab 17:251-258.
13. Garg R and Pandey KN (2003) Angiotensin II-mediated negative regulation of Npr1 promoter activity and gene transcription. Hypertension 41:730-736.
14. Garg R and Pandey KN (2005) Regulation of guanylyl cyclase/natriuretic peptide receptor-A gene expression. Peptides 26:1009-1023.
15. Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, and Di Giovanni S (2010) HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ 17:1392-1408.
16. Gomez RA and Norwood VF (1999) Recent advances in renal development. Curr Opin Pediatr 11:135-140.
17. Huang PH, Chen CH, Chou CC, Sargeant AM, Kulp SK, Teng CM, Byrd JC, and Chen CS (2011) Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases. Mol Pharmacol 79:197-206.
18. Kashyap V and Gudas LJ (2010) Epigenetic regulatory mechanisms distinguish retinoic acid-mediated transcriptional responses in stem cells and fibroblasts. J Biol Chem 285:14534-14548.
19. Khurana ML and Pandey KN (1996) Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells. Mol Cell Biochem 158:97-105.
20. Kim SH, Kang HJ, Na H, and Lee MO (2010) Trichostatin A enhances acetylation as well as protein stability of ERalpha through induction of p300 protein. Breast Cancer Res 12:R22.
21. Kishimoto K, Kinoshita K, Hino S, Yano T, Nagare Y, Shimazu H, Nozaki Y, Sugiyama M, Ikoma S, and Funauchi M (2011) Therapeutic effect of retinoic acid on unilateral ureteral obstruction model. Nephron, Exp Nephrol 118:e69-e78.
22. Kumar P, Garg R, Bolden G, and Pandey KN (2010) Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase/atrial natriuretic peptide receptor-A gene transcription. J Biol Chem 285:37521-37530.
23. Kwon HS, Huang B, Ho Jeoung N, Wu P, Steussy CN, and Harris RA (2006) Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. Biochim Biophys Acta 1759:141-151.
24. Latham JA and Dent SY (2007) Cross-regulation of histone modifications. Nat Struct Mol Biol 14:1017-1024.
25. Lee HA, Cho HM, Lee DY, Kim KC, Han HS, and Kim IK (2012) Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications. Hypertension 59:621-626.
26. Lee YS and Jeong WI (2012) Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol 27 (Suppl 2):75-79.
27. Leitman DC, Andresen JW, Catalano RM, Waldman SA, Tuan JJ, and Murad F (1988) Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. J Biol Chem 263:3720-3728.
28. Lennartsson A and Ekwall K (2009) Histone modification patterns and epigenetic codes. Biochim Biophys Acta 1790:863-868.
29. Levin ER, Gardner DG, and Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321-328.
30. Li Y, Saito Y, Kuwahara K, Rong X, Kishimoto I, Harada M, Adachi Y, Nakanishi M, Kinoshita H, and Horiuchi M et al. (2009) Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart. Endocrinology 150:3759-3765.
31. Liu C, Chen Y, Kang Y, Ni Z, Xiu H, Guan J, and Liu K (2011) Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure. J Pharmacol Exp Ther 339:203-209.
32. Liu X, Lü L, Tao BB, and Zhu YC (2008) All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-beta1 and Ang II in rat mesangial cells. Acta Pharmacol Sin 29:1035-1041.
33. Marumo T, Hishikawa K, Yoshikawa M, Hirahashi J, Kawachi S, and Fujita T (2010) Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol 298:F133-F141.
34. Nightingale KP, Gendreizig S, White DA, Bradbury C, Hollfelder F, and Turner BM (2007) Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem 282:4408-4416.
35. Nishikimi T, Inaba-Iemura C, Ishimura K, Tadokoro K, Koshikawa S, Ishikawa K, Akimoto K, Hattori Y, Kasai K, and Minamino N et al. (2009) Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice. Regul Pept 154:44-53.
36. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, and Maeda N (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94:14730-14735.
37. Oliver PM, John SW, Purdy KE, Kim R, Maeda N, Goy MF, and Smithies O (1998) Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci USA 95:2547-2551.
38. Oseto S, Moriyama T, Kawada N, Nagatoya K, Takeji M, Ando A, Yamamoto T, Imai E, and Hori M (2003) Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis. Kidney Int 64:1241-1252.
39. Pandey KN (2008) Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens 2:210-226.
40. Pandey KN (2011) The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms. FEBS J 278:1792-1807.
41. Pandey KN, Nguyen HT, Li M, and Boyle JW (2000) Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem Biophys Res Commun 271:374-379.
42. Pandey KN, Oliver PM, Maeda N, and Smithies O (1999) Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Endocrinology 140:5112-5119.
43. Pandey KN and Singh S (1990) Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J Biol Chem 265:12342-12348.
44. Pang M, Kothapally J, Mao H, Tolbert E, Ponnusamy M, Chin YE, and Zhuang S (2009) Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol 297:F996-F1005.
45. Pascual M, Do Couto BR, Alfonso-Loeches S, Aguilar MA, Rodriguez-Arias M, and Guerri C (2012) Changes in histone acetylation in the prefrontal cortex of ethanol-exposed adolescent rats are associated with ethanol-induced place conditioning. Neuropharmacology 62:2309-2319.
46. Peserico A and Simone C (2011) Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol 2011:371832.
47. Pitzalis MV, Sarzani R, Dessì-Fulgheri P, Iacoviello M, Forleo C, Lucarelli K, Pietrucci F, Salvi F, Sorrentino S, and Romito R et al. (2003) Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 21:1491-1496.
48. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, and Bianchi G et al. (2006) Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 48:499-505.
49. Schaier M, Liebler S, Schade K, Shimizu F, Kawachi H, Grone HJ, Chandraratna R, Ritz E, and Wagner J (2004) Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat. J Mol Med (Berl) 82:116-125.
50. Shi SJ, Nguyen HT, Sharma GD, Navar LG, and Pandey KN (2001) Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am J Physiol Renal Physiol 281:F665-F673.
51. Simioniuc A, Campan M, Lionetti V, Marinelli M, Aquaro GD, Cavallini C, Valente S, Di Silvestre D, Cantoni S, and Bernini F et al. (2011) Placental stem cells pretreated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study. Cardiovasc Res 90:546-556.
52. Sun X, Zhang B, Hong X, Zhang X, and Kong X (2013) Histone deacetylase inhibitor, sodium butyrate, attenuates gentamicin-induced nephrotoxicity by increasing prohibitin protein expression in rats. Eur J Pharmacol 707:147-154.
53. Tremblay J, Hum DH, Sanchez R, Dumas P, Pravenec M, Krenova D, Kren V, Kunes J, Pausova Z, and Gossard F et al. (2003) TA repeat variation, Npr1 expression, and blood pressure: impact of the Ace locus. Hypertension 41:16-24.
54. Vellaichamy E, Khurana ML, Fink J, and Pandey KN (2005) Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J Biol Chem 280:19230-19242.
55. Ventura C, Cantoni S, Bianchi F, Lionetti V, Cavallini C, Scarlata I, Foroni L, Maioli M, Bonsi L, and Alviano F et al. (2007) Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem 282:14243-14252.
56. Wei LN (2003) Retinoid receptors and their coregulators. Annu Rev Pharmacol Toxicol 43:47-72.
57. Wu M, Zhang Y, Wu NH, and Shen YF (2009) Histone marks and chromatin remodelers on the regulation of neurogenin1 gene in RA induced neuronal differentiation of P19 cells. J Cell Biochem 107:264-271.
58. Yang XJ and Seto E (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26:5310-5318.
59. Zhao D, Das S, and Pandey KN (2013) Interactive roles of NPR1 gene-dosage and salt diets on cardiac angiotensin II, aldosterone and pro-inflammatory cytokines levels in mutant mice. J Hypertens 31:134-144.
60. Zile MH (2010) Vitamin A-not for your eyes only: requirement for heart formation begins early in embryogenesis. Nutrients 2:532-550.